Sign in

    Steven Etoch • Stephens Inc.

    Steven Etoch's questions to STERIS plc (STE) leadership

    Steven Etoch's questions to STERIS plc (STE) leadership • Q4 2025

    Question

    Steven Etoch requested more detail on the customer dynamics within the AST segment that support the 6-7% growth outlook and asked if there have been any notable changes in client behavior in Life Sciences or AST due to the current macro environment.

    Answer

    President and CEO Daniel Carestio explained the AST outlook reflects a conservative approach, factoring in month-to-month volume variability and a cautious view on the bioprocessing recovery timeline. He noted that while discussions with clients about the macro environment are ongoing, there have been no concrete changes in behavior to report.

    Ask Fintool Equity Research AI

    Steven Etoch's questions to Stevanato Group SpA (STVN) leadership

    Steven Etoch's questions to Stevanato Group SpA (STVN) leadership • Q1 2025

    Question

    Steven Etoch asked if there was a shift in customer ordering patterns due to tariffs and requested a breakdown of the margin improvement drivers between EZ-fill recovery and the new facility ramp-ups.

    Answer

    CEO Franco Stevanato confirmed that customer ordering patterns have not changed due to tariffs; the recent increase is related to the end of destocking. CFO Marco Dal Lago clarified that the primary driver of margin improvement was the operational scaling of the Latina and Fishers facilities, followed by the favorable product mix from high-value solutions.

    Ask Fintool Equity Research AI

    Steven Etoch's questions to Lifecore Biomedical Inc (LFCR) leadership

    Steven Etoch's questions to Lifecore Biomedical Inc (LFCR) leadership • Q1 2025

    Question

    Steven Etoch asked CFO Ryan Lake about his near-term focus areas, opportunities for margin improvement beyond recent announcements, and whether the company is appropriately sized for sustainable growth.

    Answer

    Ryan Lake, CFO, stated his initial focus has been on the finance team, SEC filings, and the recent capital raise. He provided detailed financial cadence expectations, projecting revenue to be split 40/60 between the first and second halves of the year, with gross profit split 30/70. Lake noted that while OpEx will be similar to the prior year, it will be front-loaded, and he anticipates mid-single-digit million-dollar cost savings in the second half, leading to adjusted EBITDA being heavily weighted to H2.

    Ask Fintool Equity Research AI